American Academy of Dermatology

In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.

New data shows complete skin clearance using bimekizumab in moderate to severe plaque psoriasis open-label extension study.

Clascoterone cream 1% phase 3 results presented at meeting.

Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.

Incoming president Mark D Kaufmann, MD, FAAD, outlined his action plan for the specialty’s rapidly changing landscape in his plenary session speech at the American Academy of Dermatology 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.

Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.

Experts detailed current evidence-based treatment guidelines for Merkel cell carcinoma at the 2022 American Academy of Dermatology (AAD)’s Annual meeting held March 25 to 29, 2022, in Boston, Massachusetts.

In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.

An expert debunks the myths surrounding sun-related factors associated with melanoma in a presentation at the 2022 American Academy of Dermatology Annual Meeting.

Anne M Chapas, MD, FAAD, discusses what to do when cosmetic procedures go wrong during a presentation at the AAD 2022 annual meeting.

Experts explored out-of-the-box solutions for treating challenging skin and hair disorders at the American Academy of Dermatology (AAD)’s 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.

Zoe Diana Draelos, MD, FAAD, explains the method of using the color wheel to guide your patients nutrition to help skin, nails, and more.

Master the dialogue about food and skin, hair and nail health.

In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."

A look at the way that skin may react to COVID-19 and the vaccine for the disease.

In their session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines,” at the current AAD annual meeting, Jonathan I. Silverberg, MD, PhD, MPH, FAAD, Peter A. Lio, MD, FAAD, Andrew Blauvelt, MD, FAAD, and Robert Sidbury, MD, MPH, FAAD, discuss updates in new therapies, clinical pearls, and potential co-morbidities.

In this video interview, Christopher Bunick, MD, PhD dives into the topic of congenital ichthyosis describing his talk on the skin condition at the American Academy of Dermatology 2022 Annual Meeting.

Dermatologists continue to be split on the pros and cons of skin cancer screening, from overdiagnosis to early detection of thin melanomas.

Determining the cause of a child's rash is important to proper diagnosis and management. Allergic contact dermatitis and eczema are 2 of most common causes.

A poster presented at AAD 2022 dives into one of the largest barriers in obtaining gender-affirming neurotoxin and filler treatment for patients—the cost.

The company announced the results from its long-term extension study, highlighting improved efficacy outcomes, quality of life, and tolerability data.

Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.

In a presentation at the current AAD annual meeting, experts discussed differential diagnoses and clinical presentations in birthmarks and hamartomas.

Mariam Totonchy, MD, and Chrysalyne D. Schmults, MD, MSCE, discuss best practices when caring for high-risk cSCC patients, including surgical vs nonsurgical options, imaging, and follow-up protocol.

The American Academy of Dermatology Annual meeting starts today, offering presentations focusing on the latest treatment updates, new data, plus much more.

Dermatologist urges colleagues to take mindful measures to avoid errors.

Lack of specific phenotypes complicates verification.

There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed.